findmyKOL

Diwakar Davar, MBBS, MSc

Enriched profile

Associate Professor of Medicine; Clinical Director, Melanoma and Skin Cancer Program; Vice-Chief/Associate Chief, Academic Affairs, Division of Hematology-Oncology · UPMC Hillman Cancer Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Pittsburgh, PA · Northeast · United StatesSpecialtyHematology / OncologyFocusHepatobiliary Cancer+6
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2021–2025

Diwakar Davar is Associate Professor of Medicine; Clinical Director, Melanoma and Skin Cancer Program; Vice-Chief/Associate Chief, Academic Affairs, Division of Hematology-Oncology at UPMC Hillman Cancer Center. OpenAlex indexes 333 publications with 6,346 citations (h-index 31); ClinicalTrials.gov lists 17 registered studies with this person as an investigator.

Data verified 25 Aug 2026

Overview

Updated 14 Oct 2026

Diwakar Davar is Associate Professor of Medicine at UPMC Hillman Cancer Center / University of Pittsburgh. The public record shows 333 publications with 6,346 citations (h-index 31), centered on Hepatobiliary Cancer, Kidney Cancer / RCC, Lung Cancer (NSCLC/SCLC). It also documents an investigator role on 17 registered clinical trials, industry payments reported by 22 companies, 1 NIH-funded awards (2021–2025).

  • Most recent indexed publication: 2026 · Journal for immunotherapy of cancer
  • Top research focus: Hepatobiliary Cancer
  • 17 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 22 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Melanoma13 trialsLung Cancer (NSCLC/SCLC)3 trialsColorectal Cancer2 trialsSmall Cell Lung Carcinoma2 trialsCarcinoma, Squamous Cell2 trialsKidney Cancer / RCC2 trialsGastroesophageal Cancer2 trialsHepatobiliary Cancer2 trialsOvarian / Gynecologic Cancer2 trialsEsophageal Neoplasms2 trialsColitis2 trialsBasal Cell Carcinoma1 trialCarcinoma, Merkel Cell1 trialUveal Melanoma1 trialIBD (Crohn's / UC)1 trialUterine Cervical Neoplasms1 trialRectal Neoplasms1 trialColitis, Ulcerative1 trialUlcer1 trialEndometrial Neoplasms1 trial

Research focus

OpenAlex concept fingerprint
Hepatobiliary CancerKidney Cancer / RCCLung Cancer (NSCLC/SCLC)MelanomaOvarian / Gynecologic CancerGastroesophageal CancerColorectal Cancer

Drugs & molecules

across trials, industry payments and publications
Keytrudageneric · PembrolizumabClinical trials—Industry payments2Publications5Mekinistgeneric · TrametinibClinical trials—Industry payments2Publications1Kimmtrakgeneric · TebentafuspClinical trials—Industry payments12Publications—Libtayogeneric · CemiplimabClinical trials—Industry payments10Publications—Amtagvigeneric · LifileucelClinical trials—Industry payments2Publications—Braftovigeneric · EncorafenibClinical trials—Industry payments1Publications—Lenvimageneric · LenvatinibClinical trials—Industry payments1Publications—Mektovigeneric · BinimetinibClinical trials—Industry payments1Publications—MelphalanClinical trials—Industry payments1Publications—Proleukingeneric · AldesleukinClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Merck Sharp & Dohme LLCClinical trials—Industry payments28Immunocore LimitedClinical trials—Industry payments14Diwakar DavarClinical trials12Industry payments—Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments12Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments11Ascendis Pharma IncClinical trials—Industry payments9Novartis Pharmaceuticals CorporationClinical trials—Industry payments4TriSalus Life Sciences, Inc.Clinical trials—Industry payments4Ge HealthcareClinical trials—Industry payments2GlaxoSmithKline, LLC.Clinical trials—Industry payments2Iovance Biotherapeutics, Inc.Clinical trials—Industry payments2National Cancer Institute (NCI)Clinical trials2Industry payments—Shionogi IncClinical trials—Industry payments2Abbvie Inc.Clinical trials—Industry payments1Array Biopharma IncClinical trials—Industry payments1AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Clinigen, Inc.Clinical trials—Industry payments1Compass TherapeuticsClinical trials1Industry payments—Delcath SystemsClinical trials—Industry payments1E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Eikon TherapeuticsClinical trials1Industry payments—Eisai Inc.Clinical trials—Industry payments1Genmab U.S., Inc.Clinical trials—Industry payments1Genzyme CorporationClinical trials—Industry payments1Gilead Sciences, Inc.Clinical trials—Industry payments1Zarour, Hassane, MDClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
333publications

Distinct works indexed by OpenAlex, matched via ORCID; 40 in PubMed.

6,346citations

Total citations across indexed works.

31h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
17clinical trials

Investigator role on registered studies.

View trials ↓
22companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2021–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:

All 17 trial records: search, sort and filter.Explore →

Industry payments

Updated 14 Oct 2026

22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 33 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    38.5%
    Corticosteroid38.5%
    Hydrocortisone100%
    Part D<11 patients

  • Metabolism & gastrointestinal

    28%
    Corticosteroid28%
    Prednisone100%
    Part D≥24 patients

  • Hormonal (systemic)

    17.5%
    l-Thyroxine17.5%
    Levothyroxine Sodium100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)35.6% facility · 64.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:

All 10 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 40 publications: search, sort and filter.Explore →

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/diwakar-davar-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/diwakar-davar-253b244b

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Diwakar-Davar

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/diwakardavar

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/story.php

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Instagram

    instagram.com/emedeventsofficial/p/DDxxHhNzSLX

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
  • Instagram

    instagram.com/p/Cx8bAF3Mxu6

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn profile (auth-walled) titled "Diwakar Davar - Vice-Chief, Academic Affairs", corroborating current DOM title

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MSc

    University of Pittsburgh

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
  • MBBS

    National University of Singapore

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
  • Board certified

    Internal Medicine (ABIM)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
  • Board certified

    Medical Oncology (ABIM)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗

Editorial & leadership roles

journal and society appointments
  • Associate Professor of Medicine

    University of Pittsburgh School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
  • Clinical Director

    Melanoma and Skin Cancer Program, UPMC Hillman Cancer Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗
  • Associate Chief/Vice-Chief

    Academic Affairs, Division of Hematology-Oncology, University of Pittsburgh

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.dom.pitt.edu ↗

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.